Deanol glutamate | CAS#22199-70-8 | central stimulant

MedKoo Cat#: 597115 | Name: Deanol glutamate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Deanol glutamate is a central stimulant.

Chemical Structure

Deanol glutamate

CAS#22199-70-8

Theoretical Analysis

MedKoo Cat#: 597115

Name: Deanol glutamate

CAS#: 22199-70-8

Chemical Formula: C9H20N2O5

Exact Mass:

Molecular Weight: 236.26

Elemental Analysis: C, 45.75; H, 8.53; N, 11.86; O, 33.86

Price and Availability

This product was removed for the commercial reasons.

Related CAS #

No Data

Synonym

Deanol glutamate;

IUPAC/Chemical Name

2-(dimethylamino)ethan-1-ol L-glutamate

InChi Key

IKFZABILOXSNSM-DFWYDOINSA-N

InChi Code

InChI=1S/C5H9NO4.C4H11NO/c6-3(5(9)10)1-2-4(7)8;1-5(2)3-4-6/h3H,1-2,6H2,(H,7,8)(H,9,10);6H,3-4H2,1-2H3/t3-;/m0./s1

SMILES Code

N[C@@H](CCC(O)=O)C(O)=O.CN(CCO)C

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 236.26 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Smulevich AB, Chitlova VV, Germanova KN. [Nooklerin (deanoli aceglumas) in the treatment of astenic and cognitive disorders in patients with borderline psychopatological conditions]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(9):31-36. doi: 10.17116/jnevro20171179131-36. Russian. PubMed PMID: 29053118. 2: Noskov DS, Poroĭkov VV, Shikh EV, Iasnetsov VV. [Deanol aceglumate (nooclerin): clinical/pharmacological aspects and relevance in clinical practice]. Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(11):97-9. Russian. PubMed PMID: 24429957. 3: Dubois B, Zaim M, Touchon J, Vellas B, Robert P, Murphy MF, Pujadas-Navinés F, Rainer M, Soininen H, Riordan HJ, Kanony-Truc C. Effect of six months of treatment with V0191 in patients with suspected prodromal Alzheimer's disease. J Alzheimers Dis. 2012;29(3):527-35. doi: 10.3233/JAD-2012-111370. PubMed PMID: 22330824. 4: Blin O, Audebert C, Pitel S, Kaladjian A, Casse-Perrot C, Zaim M, Micallef J, Tisne-Versailles J, Sokoloff P, Chopin P, Marien M. Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies. Psychopharmacology (Berl). 2009 Dec;207(2):201-12. doi: 10.1007/s00213-009-1648-7. Epub 2009 Sep 16. PubMed PMID: 19756528. 5: Misdaq MA, Karime M. Analysis of 238U, 232Th, 222Rn, and 220Rn in different medical drug preparations by using CR-39 and LR-115 typE II SSNTDs and resulting radiation doses to adult patients. Health Phys. 2009 Jan;96(1):27-36. doi: 10.1097/01.HP.0000326446.28153.29. PubMed PMID: 19066484. 6: Kuye RA, Donham KJ, Marquez SP, Sanderson WT, Fuortes LJ, Rautiainen RH, Jones ML, Culp KR. Pesticide handling and exposures among cotton farmers in the gambia. J Agromedicine. 2007;12(3):57-69. PubMed PMID: 19042671. 7: Sonesson A, Oqvist B, Hagstam P, Björkman-Burtscher IM, Miörner H, Petersson AC. An immunosuppressed patient with systemic vasculitis suffering from cerebral abscesses due to Nocardia farcinica identified by 16S rRNA gene universal PCR. Nephrol Dial Transplant. 2004 Nov;19(11):2896-900. PubMed PMID: 15496565. 8: Zolotov NN, Kutenova OA, Voronina TA, Pozdnev VF, Smirnov LD, Diumaev KM. [The possible participation of brain peptidases in regulating the memory function during aging]. Dokl Akad Nauk SSSR. 1991;317(1):234-7. Russian. PubMed PMID: 1868772. 9: Voronina TA, Garibova TL, Sopyev ZhA, Voronin KE. [Psychotropic properties of nootropic substances with a cholinergic action component in single and long-term use]. Farmakol Toksikol. 1987 Sep-Oct;50(5):12-5. Russian. PubMed PMID: 3121384. 10: Markina NV, Nerobkova LN, Voronina TA. [Effect of drugs of the nootropic class on rat behavior after deprivation of the paradoxical stage of sleep]. Zh Vyssh Nerv Deiat Im I P Pavlova. 1986 Sep-Oct;36(5):963-7. Russian. PubMed PMID: 3099498. 11: Bielenberg GW, Hayn C, Krieglstein J. Effects of cerebro-protective agents on enzyme activities of rat primary glial cultures and rat cerebral cortex. Biochem Pharmacol. 1986 Aug 15;35(16):2693-702. PubMed PMID: 2943286. 12: Voronina TA, Krapivin SV, Nerobkova LN. [Specificity of the action of piracetam, encephabol and Cleregil on the transcallosal evoked potential]. Biull Eksp Biol Med. 1986 Mar;101(3):320-2. Russian. PubMed PMID: 3955218. 13: Garibova TL, Voronin KE, Rudenko GM. [Role of cholinergic systems in the formation of a dissociated state in response to kleregil]. Biull Eksp Biol Med. 1984 Nov;98(11):570-2. Russian. PubMed PMID: 6542433. 14: Rugginenti A. [Effects of dimethylaminoethanol acetyl glutamate on the attentive capacity of a group of soccer players]. Arch Maragliano Patol Clin. 1974 Jul-Dec;30(2):189-98. Italian. PubMed PMID: 4480705. 15: LEGER R, FERRIERE JP, GROS JJ. [CLINICAL STUDY OF CR 121 IN A HOSPITAL SERVICE]. Prog Med (Paris). 1964 Jun 24;92:457-63. French. PubMed PMID: 14174399. 16: RAVINA A. [CLINICAL STUDY OF DIMETHYLAMINOETHANOL ACETYLGLUTAMATE IN ADULTS AND AGED PERSONS]. Prog Med (Paris). 1964 Mar 24;92:189-93. French. PubMed PMID: 14141254.